Skip to Main Content

Paper Details

Risk of malignant melanoma and non-melanoma skin cancer in rheumatoid arthritis patients initiating methotrexate versus hydroxychloroquine: a cohort study.
Clin Exp Rheumatol
2
2023
BCC, NMSC, RA, SCC, basal cell carcinoma, hydroxychloroquine, malignant melanoma, methotrexate, non-melanoma skin cancer, patients, person, rheumatoid arthritis, skin cancer, squamous cell carcinoma
Author NameAffiliation
Seanna VineDivision of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School
Rishi J DesaiDivision of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School
Michael E WeinblattBrigham and Women's Hospital and Harvard Medical School
  • 1 - 3

Datasets

Release 1.2